000			01111 a2200337 4500
005			20250513015301.0
264		0	_c19811029
008			198110s 0 0 eng d
022			_a0098-7484
040			_aNLM _beng _cNLM
100	1		_aHirschmann, J V
245	0	0	_aPneumococcal vaccine in the United States. A critical analysis. _h[electronic resource]
260			_bJAMA _cSep 1981
300			_a1428-32 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
650	0	4	_aAge Factors
650	0	4	_aAged
650	0	4	_aBacterial Vaccines _xadministration & dosage
650	0	4	_aChild, Preschool
650	0	4	_aEvaluation Studies as Topic
650	0	4	_aHumans
650	0	4	_aMiddle Aged
650	0	4	_aPneumococcal Infections _xprevention & control
650	0	4	_aPolysaccharides, Bacterial _xadministration & dosage
650	0	4	_aRisk
650	0	4	_aStreptococcus pneumoniae _ximmunology
650	0	4	_aUnited States
650	0	4	_aVaccination _xadverse effects
700	1		_aLipsky, B A
773	0		_tJAMA _gvol. 246 _gno. 13 _gp. 1428-32
999			_c7264965 _d7264965